Kyowa Kirin (OTCMKTS:KYKOF – Get Free Report) is projected to issue its resultson Monday, August 3rd. Analysts expect Kyowa Kirin to post earnings of $0.2093 per share and revenue of $808.42 million for the quarter.
Kyowa Kirin Price Performance
KYKOF stock opened at $14.21 on Monday. Kyowa Kirin has a 12 month low of $12.42 and a 12 month high of $18.00. The company has a 50-day moving average price of $14.35 and a 200 day moving average price of $14.57.
About Kyowa Kirin
Kyowa Kirin Co, Ltd. is a global biopharmaceutical company headquartered in Tokyo, Japan, specializing in the research, development and commercialization of innovative therapies. Established through the merger of Kyowa Hakko Kogyo Co, Ltd. and Kirin Pharma Co, Ltd. in 2008, the company operates as part of the Kirin Group and pursues a mission of delivering cutting-edge medicines in areas of high unmet medical need. Its corporate structure supports integrated research and development, manufacturing and worldwide licensing activities.
The company’s therapeutic focus spans oncology, nephrology, immunology and central nervous system disorders.
See Also
- Five stocks we like better than Kyowa Kirin
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
- Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit
Receive News & Ratings for Kyowa Kirin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kyowa Kirin and related companies with MarketBeat.com's FREE daily email newsletter.
